Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

被引:0
作者
Hoisnard, Lea [1 ]
Maury, Sebastien [2 ,3 ]
Mahevas, Matthieu [4 ]
El Karoui, Khalil [5 ]
Roy, Lydia [6 ]
Cohen, Jose L. [7 ]
Amiot, Aurelien [8 ,9 ]
Claudepierre, Pascal [10 ]
Grimbert, Philippe [11 ]
Sbidian, Emilie [12 ]
机构
[1] Hop La Pitie Salpetriere, AP HP, Dept Pharmacol, Pharmacovigilance Unit, Paris, France
[2] UPEC Univ Paris Est Creteil, Henri Mondor Hosp, Dept Hematol, AP HP, F-94010 Creteil, France
[3] UPEC Univ Paris Est Creteil, Fac Sante, F-94010 Creteil, France
[4] Henri Mondor Hosp, AP HP, Dept Internal Med, F-94010 Creteil, France
[5] Henri Mondor Hosp, Dept Nephrol & Renal Transplantat 7, AP HP, F-94010 Creteil, France
[6] Henri Mondor Hosp, AP HP, Hematol Dept, F-94010 Creteil, France
[7] INSERM, Inst Mondor Rech Biomed IMRB, U955, F-94010 Creteil, France
[8] Henri Mondor Hosp, AP HP, Dept Gastroenterol, EA7375, Creteil, France
[9] Univ Paris Est, Creteil, France
[10] Henri Mondor Hosp, AP HP, Dept Rheumatol, F-94000 Creteil, France
[11] Henri Mondor Hosp, AP HP, Dept Nephrol & Renal Transplantat, F-94010 Creteil, France
[12] Henri Mondor Hosp, AP HP, Dept Dermatol, F-94010 Creteil, France
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
32696
引用
收藏
页码:AB137 / AB137
页数:1
相关论文
empty
未找到相关数据